4//SEC Filing
Fairbairn Malcolm 4
Accession 0001213900-20-023899
CIK 0001733413other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 6:16 PM ET
Size
5.4 KB
Accession
0001213900-20-023899
Insider Transaction Report
Form 4
Fairbairn Malcolm
Director
Transactions
- Award
Stock Options (Right to Buy)
2020-08-24+13,200→ 105,455 totalExercise: $13.65→ Common Stock (13,200 underlying)
Footnotes (1)
- [F1]Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001317314
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 6:16 PM ET
- Size
- 5.4 KB